METHOD FOR DIFFERENTIATED SELECTION OF PATIENTS WITH DIABETES MELLITUS FOR THE PLANNED OPERATION OF TOTAL HIP AND/OR KNEE ENDOPROSTHETICS Russian patent published in 2020 - IPC A61B5/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine and can be used for differentiated selection of patients with diabetes mellitus for the planned operation of total hip and / or knee endoprosthetics. Glycated hemoglobin is pre-determined, and on the eve of the operation, intestinal murmurings are recorded on a computer phoneterogram and the peristalsis type is determined from the table. Patients with a moderate and severe type of peristalsis are referred for a planned operation. For the group of patients with mild type of peristalsis, the value of intestinal peak-factor is determined, then this group of patients is given food and sugar-lowering drugs. Thereafter, IPF₂ value is determined again and IPF₁ and IPF₂ values are compared. Group of patients with IPF₁ and IPF₂ values differ by less than 30 %, are directed for the planned operation. Group of patients with IPF₂ value decreased by more than 30 % of IPF₁ value, preparations stimulating gastrointestinal motility, and sugar-lowering preparations are given. In 20–50 minutes after taking these preparations, the value of IPF₃ is determined and IPF₁ and IPF₃ values are compared. Patients with IPF₃ and IPF₁ values differ by less than 30 %, directed to planned operation. For patients with IPF₃ value lower than IPF₁ value more than 30 % planned operation is transferred on the following day and IPF₁ is determined again, if necessary IPF₂ and IPF₃ to achieve correct parameters.

EFFECT: reduced postoperative risks.

1 cl, 1 tbl